Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Patient engagement in type 2 diabetes mellitus research: what patients want.

Simacek KF, Nelson T, Miller-Baldi M, Bolge SC.

Patient Prefer Adherence. 2018 Apr 20;12:595-606. doi: 10.2147/PPA.S159707. eCollection 2018.

2.

Health care provider experience with canagliflozin in real-world clinical practice: favorability, treatment patterns, and patient outcomes.

Bolge SC, Flores NM, Huang S, Cai J.

Int J Gen Med. 2017 Jun 23;10:177-187. doi: 10.2147/IJGM.S138583. eCollection 2017.

3.

Patient experience with intravenous biologic therapies for ankylosing spondylitis, Crohn's disease, psoriatic arthritis, psoriasis, rheumatoid arthritis, and ulcerative colitis.

Bolge SC, Eldridge HM, Lofland JH, Ravin C, Hart PJ, Ingham MP.

Patient Prefer Adherence. 2017 Mar 28;11:661-669. doi: 10.2147/PPA.S121032. eCollection 2017.

4.

The association of weight loss with patient experience and outcomes in a population of patients with type 2 diabetes mellitus prescribed canagliflozin.

Gerlanc NM, Cai J, Tkacz J, Bolge SC, Brady BL.

Diabetes Metab Syndr Obes. 2017 Mar 20;10:89-99. doi: 10.2147/DMSO.S129824. eCollection 2017.

5.

Healthcare costs of urinary tract infections and genital mycotic infections among patients with type 2 diabetes mellitus initiated on canagliflozin: a retrospective cohort study.

Amos TB, Montejano L, Juneau P, Bolge SC.

J Med Econ. 2017 Mar;20(3):303-313. doi: 10.1080/13696998.2016.1259167. Epub 2016 Nov 28.

PMID:
27826987
7.

Openness to and preference for attributes of biologic therapy prior to initiation among patients with rheumatoid arthritis: patient and rheumatologist perspectives and implications for decision making.

Bolge SC, Goren A, Brown D, Ginsberg S, Allen I.

Patient Prefer Adherence. 2016 Jun 16;10:1079-90. doi: 10.2147/PPA.S107790. eCollection 2016.

8.

Depression among people with type 2 diabetes mellitus, US National Health and Nutrition Examination Survey (NHANES), 2005-2012.

Wang Y, Lopez JM, Bolge SC, Zhu VJ, Stang PE.

BMC Psychiatry. 2016 Apr 5;16:88. doi: 10.1186/s12888-016-0800-2.

9.

Changes in Body Weight Among People With Type 2 Diabetes Mellitus in the United States, NHANES 2005-2012.

Wang Y, Bolge SC, Lopez JM, Zhu VJ, Stang PE.

Diabetes Educ. 2016 Jun;42(3):336-45. doi: 10.1177/0145721716640096. Epub 2016 Mar 31.

PMID:
27033723
10.

Assessment of Rheumatoid Arthritis Quality Process Measures and Associated Costs.

Brady BL, Tkacz J, Meyer R, Bolge SC, Ruetsch C.

Popul Health Manag. 2017 Feb;20(1):31-40. doi: 10.1089/pop.2015.0133. Epub 2016 Mar 31.

11.

Prescribing Patterns of Intravenous Golimumab for Rheumatoid Arthritis.

Brady BL, Tkacz JP, Lofland J, Meyer R, Bolge SC.

Clin Ther. 2015 Sep;37(9):2028-36. doi: 10.1016/j.clinthera.2015.06.017. Epub 2015 Jul 22.

12.

Reasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: a patient perspective.

Bolge SC, Goren A, Tandon N.

Patient Prefer Adherence. 2015 Jan 20;9:121-31. doi: 10.2147/PPA.S70834. eCollection 2015.

13.

Quality process measures for rheumatoid arthritis: performance from members enrolled in a national health plan.

Tkacz J, Ellis LA, Meyer R, Bolge SC, Brady BL, Ruetsch C.

J Manag Care Spec Pharm. 2015 Feb;21(2):135-43.

14.

Utilization and adherence patterns of subcutaneously administered anti-tumor necrosis factor treatment among rheumatoid arthritis patients.

Tkacz J, Ellis L, Bolge SC, Meyer R, Brady BL, Ruetsch C.

Clin Ther. 2014 May;36(5):737-47. doi: 10.1016/j.clinthera.2014.02.019. Epub 2014 Mar 21.

15.

Comparative multidatabase analysis of dosing patterns and infusion intervals for the first 12 infliximab infusions in patients with rheumatoid arthritis.

Bolge SC, Carter CT, Mueller CS, Bailey RA, Ingham MP.

Clin Ther. 2012 Dec;34(12):2286-92. doi: 10.1016/j.clinthera.2012.10.010. Epub 2012 Nov 13.

16.

Factors associated with treatment of women with osteoporosis or osteopenia from a national survey.

Meadows ES, Mitchell BD, Bolge SC, Johnston JA, Col NF.

BMC Womens Health. 2012 Jan 6;12:1. doi: 10.1186/1472-6874-12-1.

17.

The association between Alzheimer's disease symptom severity and caregiver outcomes: a cross-sectional study.

Kannan H, Bolge SC, Del Valle M, Alvir J, Petrie CD.

Prim Care Companion CNS Disord. 2011;13(3). pii: PCC.10m01043. doi: 10.4088/PCC.10m01043.

18.

Health-related quality of life, work productivity and health care resource use associated with constipation predominant irritable bowel syndrome.

DiBonaventura M, Sun SX, Bolge SC, Wagner JS, Mody R.

Curr Med Res Opin. 2011 Nov;27(11):2213-22. doi: 10.1185/03007995.2011.623157. Epub 2011 Sep 28.

PMID:
21951105
19.

Correlates of medication adherence among patients with bipolar disorder: results of the bipolar evaluation of satisfaction and tolerability (BEST) study: a nationwide cross-sectional survey.

Bates JA, Whitehead R, Bolge SC, Kim E.

Prim Care Companion J Clin Psychiatry. 2010;12(5). pii: PCC.09m00883. doi: 10.4088/PCC.09m00883yel.

20.

Burden of chronic sleep maintenance insomnia characterized by nighttime awakenings among anxiety and depression sufferers: results of a national survey.

Bolge SC, Joish VN, Balkrishnan R, Kannan H, Drake CL.

Prim Care Companion J Clin Psychiatry. 2010;12(2). pii: PCC.09m00824. doi: 10.4088/PCC.09m00824gry.

21.

Effect of inadequate response to treatment in patients with depression.

Knoth RL, Bolge SC, Kim E, Tran QV.

Am J Manag Care. 2010 Aug;16(8):e188-96.

22.

The burden of uterine fibroids in five European countries.

Downes E, Sikirica V, Gilabert-Estelles J, Bolge SC, Dodd SL, Maroulis C, Subramanian D.

Eur J Obstet Gynecol Reprod Biol. 2010 Sep;152(1):96-102. doi: 10.1016/j.ejogrb.2010.05.012. Epub 2010 Jul 3.

PMID:
20598796
23.

Predictability of future attacks by migraineurs: a prospective observational study.

Hu XH, Golden W, Bolge SC, Katic B, Chen YT, Wagner S, Cady R.

Headache. 2010 Sep;50(8):1296-305. doi: 10.1111/j.1526-4610.2010.01630.x. Epub 2010 Mar 4.

PMID:
20236350
24.
25.

Burden of chronic sleep maintenance insomnia characterized by nighttime awakenings.

Bolge SC, Joish VN, Balkrishnan R, Kannan H, Drake CL.

Popul Health Manag. 2010 Feb;13(1):15-20. doi: 10.1089/pop.2009.0028.

26.

The burden of disrupting gastro-oesophageal reflux disease: a database study in US and European cohorts.

Toghanian S, Wahlqvist P, Johnson DA, Bolge SC, Liljas B.

Clin Drug Investig. 2010;30(3):167-78. doi: 10.2165/11531670-000000000-00000.

PMID:
20155989
27.

Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life.

Pollack MF, Purayidathil FW, Bolge SC, Williams SA.

Diabetes Res Clin Pract. 2010 Feb;87(2):204-10. doi: 10.1016/j.diabres.2009.11.023. Epub 2009 Dec 29.

PMID:
20036433
28.

Burden associated with chronic sleep maintenance insomnia characterized by nighttime awakenings among women with menopausal symptoms.

Bolge SC, Balkrishnan R, Kannan H, Seal B, Drake CL.

Menopause. 2010 Jan-Feb;17(1):80-6. doi: 10.1097/gme.0b013e3181b4c286.

PMID:
19730276
29.

The association between asthma control and health care utilization, work productivity loss and health-related quality of life.

Williams SA, Wagner S, Kannan H, Bolge SC.

J Occup Environ Med. 2009 Jul;51(7):780-5. doi: 10.1097/JOM.0b013e3181abb019.

PMID:
19528828
30.

Frequency of diagnosis and treatment of allergic rhinitis among adults with asthma in Germany, France, and the UK: National Health and Wellness Survey.

Sazonov V, Ambegaonkar BM, Bolge SC, Radican L, Fan T, Taylor SD.

Curr Med Res Opin. 2009 Jul;25(7):1721-6. doi: 10.1185/03007990902915061.

PMID:
19505203
31.

Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK.

Demoly P, Paggiaro P, Plaza V, Bolge SC, Kannan H, Sohier B, Adamek L.

Eur Respir Rev. 2009 Jun;18(112):105-12. doi: 10.1183/09059180.00001209.

32.

Burden of illness associated with lower urinary tract symptoms including overactive bladder/urinary incontinence.

Kannan H, Radican L, Turpin RS, Bolge SC.

Urology. 2009 Jul;74(1):34-8. doi: 10.1016/j.urology.2008.12.077. Epub 2009 May 9.

PMID:
19428076
33.

Effects of gastroesophageal reflux disease on sleep and outcomes.

Mody R, Bolge SC, Kannan H, Fass R.

Clin Gastroenterol Hepatol. 2009 Sep;7(9):953-9. doi: 10.1016/j.cgh.2009.04.005. Epub 2009 Apr 16.

PMID:
19375520
34.

Association of insomnia with quality of life, work productivity, and activity impairment.

Bolge SC, Doan JF, Kannan H, Baran RW.

Qual Life Res. 2009 May;18(4):415-22. doi: 10.1007/s11136-009-9462-6. Epub 2009 Mar 14.

PMID:
19288223
35.

The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1).

Bell TJ, Panchal SJ, Miaskowski C, Bolge SC, Milanova T, Williamson R.

Pain Med. 2009 Jan;10(1):35-42. doi: 10.1111/j.1526-4637.2008.00495.x. Epub 2008 Aug 18.

PMID:
18721170
36.

Economic and humanistic outcomes associated with comorbid type-2 diabetes, high cholesterol, and hypertension among individuals who are overweight or obese.

Kannan H, Thompson S, Bolge SC.

J Occup Environ Med. 2008 May;50(5):542-9. doi: 10.1097/JOM.0b013e31816ed569.

PMID:
18469623
37.
38.

Relationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort.

Wahlqvist P, Karlsson M, Johnson D, Carlsson J, Bolge SC, Wallander MA.

Aliment Pharmacol Ther. 2008 May;27(10):960-70. doi: 10.1111/j.1365-2036.2008.03671.x. Epub 2008 Feb 29.

39.
40.

Quality of life among bipolar disorder patients misdiagnosed with major depressive disorder.

Awad AG, Rajagopalan K, Bolge SC, McDonnell DD.

Prim Care Companion J Clin Psychiatry. 2007;9(3):195-202.

41.

Patient satisfaction with extended release tolterodine or oxybutynin in overactive bladder.

Bolge SC, McDonnell DD, Chen A, Wan GJ.

Curr Med Res Opin. 2007 Aug;23(8):1903-12. Review.

PMID:
17610806
42.
43.

The impact of anemia on quality of life and healthcare resource utilization in patients with HIV/AIDS receiving antiretroviral therapy.

Bolge SC, Mody S, Ambegaonkar BM, McDonnell DD, Zilberberg MD.

Curr Med Res Opin. 2007 Apr;23(4):803-10.

PMID:
17407637
44.

Treatment satisfaction with a transdermal contraceptive patch or oral contraceptives.

Wan GJ, Barnowski CE, Ambegaonkar BM, Bolge SC, McDonnell DD.

Contraception. 2007 Apr;75(4):281-4. Epub 2007 Feb 16.

PMID:
17362706
45.

Effectiveness versus convenience: patient preferences for an erythropoietic agent to treat cancer-related anemia.

Langer CJ, Fastenau JM, Forlenza JB, Tak Piech C, Bolge SC, Gano Allen J, Zilberberg MD.

Curr Med Res Opin. 2007 Jan;23(1):85-92.

PMID:
17257469

Supplemental Content

Loading ...
Support Center